Company
A team that's shipped drugs and shipped software.
AlphaMeld Corporation is a wholly owned subsidiary of InveniAI LLC, founded in 2014 and rebranded as AlphaMeld in 2025. We operate from Guilford, Connecticut, with a European site in Basel, Switzerland — at the heart of the global pharmaceutical industry.
2014Founded (as InveniAI)
2Global sites
10+Active pharma partnerships
Phase IIIHighest AI-identified candidate
Offices
Two sites, one engineering organization.
HQ
Guilford, Connecticut
2614 Boston Post Road Suite #33B, Guilford, CT 06437. Platform engineering, scientific leadership, and corporate operations.
EU
Basel, Switzerland
Data sciences, European partnerships, and engagement with the global pharmaceutical innovation ecosystem.